Important Update: August 10, 2020

We’re pleased to announce a collaboration agreement with Ascensia Diabetes Care, maker of the CONTOUR® portfolio of blood glucose monitoring systems, to become our exclusive global commercial partner and distributor to bring Eversense®, the first and only long-term CGM system in the world, to patients and providers worldwide effective in 2021.

To learn more, click here.

Paragraphs
Inner Content
 

Why Eversense CGM?

 
sensor

90 days

The FDA-approved long-term CGM that lasts up to 90 days.

The advanced sensor technology and under-the-skin sensor help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.

 

The only CGM with a powerful

23.4 HOURS A DAY WEAR TIME1,2

 
Selector Id
why-eversense-cgm
Selector Class
why-eversense-cgm

Eversense

Up to 90-day sensor life

4 sensor changes per year

Only 4 ‘Day 1' warm-up periods

Sensor placement by HCP

Sensor reads glucose values even without transmitter

Sensor stays put no matter what

No irritation from silicone-based transmitter adhesive1

Traditional CGMs

Short sensor life of 7-14 days

26-52 sensor changes per year

26 - 52 ‘Day 1’ warm-up periods

Need to self-insert the sensor

Transmitter must remain adhered to skin for sensor duration

Percutaneous sensor can be dislodged during normal activities

Acrylate-based adhesives can cause irritation

 

How we outpace other CGMS

 
Selector Id
eversense-cgm-system-comp
Selector Class
eversense-cgm-system-comp bg-center-center-tab bg-center-center-mobile
Become a provider
doctor patient
 

Become a provider

 
1

Register for training

2

Begin learning

3

Receive support

4

Start treating patients

Selector Class
become-a-provider
Content

Freedom, flexibility and empowerment.

Dr. David Ahn, Eversense CGM provider

Selector Id
user-comment-section
Selector Class
user-comment-section
Selector Class
section-lists